Relationship among the severity of the disease measured according to the oxygen desaturation index, and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).

<p>Relationship among the severity of the disease measured according to the oxygen desaturation index, and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).</p

Relationship between CD31⁺/annexin V⁺ MPs and circulating cf-DNA.

<p>Relationship between CD31⁺/annexin V⁺ MPs and circulating cf-DNA.</p

Relationship among the severity of the disease measured according to the mean oxygen saturation (%), and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).

<p>Relationship among the severity of the disease measured according to the mean oxygen saturation (%), and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).</p

Relationship between flow mediated dilatation measured by Laser-Doppler flowmetry (hyperaemic area) and vascular endothelial growth factor (VEGF).

<p>Relationship between flow mediated dilatation measured by Laser-Doppler flowmetry (hyperaemic area) and vascular endothelial growth factor (VEGF).</p

Relationship among the severity of the disease measured according to the apnoea-hypopnea index and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).

<p>Relationship among the severity of the disease measured according to the apnoea-hypopnea index and changes from baseline in circulating cf-DNA, CD31⁺/annexin V⁺ MPs and vascular endothelial growth factor (VEGF).</p

Baseline characteristics of the patients.

<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>Baseline characteristics of the patients.</p

Changes of blood pressure, flow-mediated dilation, CD31⁺/annexin V⁺microparticles, circulating cell-free DNA and VEGF after CPAP.

<p>Data are shown as mean ± SD (95% confidence intervals) or n (%).</p><p>(*) Pulse pressure (PP) is defined as systolic minus diastolic blood pressure. AR: abnormal readings; cf-DNA: circulating cell-free DNA; CPAP: continuous positive pressure airway; DBP: Diastolic Blood Pressure; FMD: Flow mediated dilatation; MPs: microparticles; PP: pulse pressure; SBP: Systolic Blood Pressure; VEGF: Vascular endothelial growth factor.</p><p>Changes of blood pressure, flow-mediated dilation, CD31⁺/annexin V⁺microparticles, circulating cell-free DNA and VEGF after CPAP.</p